ENTITY
Hutchison China MediTech Ltd

Hutchison China MediTech Ltd (HCM US)

41
Analysis
Health CareHong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
26 Jan 2020 11:42

ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Happy...

Share
22 Jan 2020 18:02

Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind

HCM, a leading China biotech company, filed a prospectus to sell USD 110 million of ADS. We have covered the company's fundamentals for its Hong...

Logo
490 Views
Share
28 Jun 2019 16:51

Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed

HCM, a leading China biotech company, filed a prospectus to sell 8.5 million secondary ADSs. We have covered the company's fundamentals for its...

Logo
530 Views
Share
bullishESR Group
08 Jun 2019 12:16

ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
25 Apr 2019 15:23

Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities

Hutchison-China Meditech, China-based AIM and NASDAQ dual listed pharmaceutical company, is seeking to raise up to USD 500 million via a Hong Kong...

Logo
669 Views
Share
x